Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

STO/HNSA stock hub

STO/HNSA has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

STO/HNSAis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

2.9B

Nasdaq Stockholm

Market data

Live price

Current market quote for this ticker.

Current price

STO/HNSA

In the news

Latest news · STO/HNSA

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 14.9P50 22.5P75 31.5

Trailing P/En/a

P25 17.3P50 29.9P75 44.5

ROEn/a

P25 -86.1P50 -28.3P75 4.6

ROIC-56.5

P25 -52.4P50 -16.9P75 5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All STO/HNSA market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

169

Groups with data

Currency

SEK

Showing 169 of 169 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Sweden
Country code	SE
Employees	122
Employees Change	-16%
Employees Change Percent	-11.59
Enterprise value	SEK 3.4B
Exchange	Nasdaq Stockholm
Financial currency	SEK
First seen	2026-05-10
Industry	Biotechnology
Isin	SE0002148817
Last refreshed	2026-05-10
Market cap	SEK 2.9B
Price	SEK 28.52
Price currency	SEK
Rev Per Employee	1,561,360.66x
Sector	Healthcare
Sic	2836
Symbol	sto/HNSA
Website	https://www.hansabiopharma.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-23.83%
EV Earnings	-4.87x
EV/Sales	17.68x
P/B ratio	-10.54x
P/S ratio	15.24x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-299.37%
EBITDA Margin	-298.07%
Gross margin	59.67%
Gross Profit	SEK 113.7M
Gross Profit Growth	18.68%
Gross Profit Growth Q	-54.64%
Gross Profit Growth3 Y	0.63%
Gross Profit Growth5 Y	57.03%
Net Income	SEK -691.6M
Net Income Growth Years	2%
Pretax Margin	-361.81%
Profit Per Employee	SEK -5.7M
ROA	-38.17
Roa5y	-33.49
ROCE	-60.45
ROIC	-56.51

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-2.6%
Cagr15y	10.94%
Cagr1y	10.81%
Cagr3y	-19.36%
Cagr5y	-28.29%
EPS Growth Years	2
Revenue Growth	4.85x
Revenue Growth Q	-47.9x
Revenue Growth Years	2x
Revenue Growth3 Y	8.67x
Revenue Growth5 Y	68.05x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	SEK 0.2
Assets	SEK 1.2B
Cash	SEK 676.5M
Current Assets	SEK 794.3M
Current Liabilities	SEK 218.8M
Debt	SEK 1.1B
Equity	SEK -275.3M
Interest Coverage	-2.55
Liabilities	SEK 1.4B
Long Term Assets	SEK 367.9M
Long Term Liabilities	SEK 1.2B
Net Cash	SEK -465.8M
Net Cash By Market Cap	SEK -16.05
Tangible Book Value	SEK -509.5M
Tangible Book Value Per Share	SEK -5.01
WACC	13.31

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	3.63
Inventory Turnover	17.2
Net Working Capital	SEK -94.7M
Quick ratio	3.6
Working Capital	SEK 575.5M
Working Capital Turnover	SEK 0.48

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-34.63%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-23.13%
1Y total return	10.8%
200-day SMA	31.96
3Y total return	-47.57%
50-day SMA	29.68
50-day SMA vs 200-day SMA	50under200
5Y total return	-81.04%
All Time High	349.4
All Time High Change	-91.84%
All Time High Date	2018-10-04
All Time Low	2.42
All Time Low Change	1,078.51%
All Time Low Date	2012-10-23
ATR	1.44
Beta	1.49
Beta1y	1.27
Beta2y	1.06
Ch YTD	-17
High	28.9
High52	42.98
High52 Date	2025-10-01
High52ch	-33.64%
Low	27.86
Low52	22.82
Low52 Date	2025-06-02
Low52ch	24.98%
Ma50ch	-3.91%
Price vs 200-day SMA	-10.75%
RSI	49.3
RSI Monthly	44.03
RSI Weekly	45.52
Sharpe ratio	0.29x
Sortino ratio	0.52
Total Return	-34.63%
Tr YTD	-17
Tr15y	374.5%
Tr1m	-4.3%
Tr1w	0.85%
Tr3m	-21.26%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	SEK -570.3M
Operating margin	-299.4

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	74,057,974%
Net Borrowing	116,156,000
Shares Insiders	6.12%
Shares Institutions	21.68%
Shares Out	101,763,222
Shares Qo Q	0%
Shares Yo Y	34.63%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	460,945.1x
Bv Per Share	-2.7
Ch10y	-23.13
Ch15y	263.3
Ch1m	-4.3
Ch1w	0.85
Ch1y	10.8
Ch3m	-21.26
Ch3y	-47.57
Ch5y	-81.04
Ch6m	5.63
Change	-0.21%
Change From Open	0.07
Close	28.58
Days Gap	-0.28
Depreciation Amortization	2,490,500
Dollar Volume	3,992,999.6
Earnings Date	2026-07-16
EBIT	SEK -570.3M
EBITDA	SEK -567.8M
EPS	SEK -7.71
F Score	3
Financing CF	981,856,000
Fiscal Year End	December
Founded	2,007
Income Tax	SEK 2.4M
Is Primary Listing	1
Last Earnings Date	2026-03-26
Last Report Date	2026-03-31
Ma150	32.34
Ma150ch	-11.82%
Ma20	28.06
Ma20ch	1.64%
Net CF	426,262,000
Next Earnings Date	2026-07-16
Open	28.5
Position In Range	63.46
Ppne	10,665,000
Price Date	2026-05-08
Relative Volume	0.3x
Revenue	190,486,000x
SBC By Revenue	18.26x
Share Based Comp	34,787,000
Tax By Revenue	1.25x
Tr6m	5.63%
Volume	140,007

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does STO/HNSA pay a dividend?

Capital-return profile for this ticker.

Performance

STO/HNSA stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns STO/HNSA?

Insider, institutional, and short-interest positioning.

Institutional ownership

+21.7%

Share of float held by funds and institutions

Insider ownership

+6.1%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+34.6%

Negative means the company is buying back shares.

Technical

STO/HNSA momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

49.3

Neutral momentum band

Price vs 200-day MA

-10.7%

50/200-day relationship not available

Beta (5Y)

1.49

More volatile than the market

Sharpe ratio

0.29

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About STO/HNSA

Hub-level FAQ points readers to the deeper analysis pages.

What is the current sto/HNSA stock rating?

sto/HNSA is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full sto/HNSA analysis?

The full report lives at /stocks/sto/HNSA/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for sto/HNSA?

The latest report frames sto/HNSA around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the sto/HNSA page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.